MIT's AI method stabilized experimental mRNA vaccine particles for up to one year at room temperature, potentially cutting ...

RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer ...

The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was ...

Skepticism about the government’s pandemic response is one thing. Writing off mRNA vaccine technology is another.

New trial data in melanoma and early findings in head and neck cancer are advancing individualized vaccines, while questions ...

Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.

Ottawa, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The global RNA therapeutics and vaccines market size is calculated at USD 0.38 billion in 2025 and is expected to reach around USD 107.7 billion by 2034, ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Canada’s LNP expertise, public funding, evolving regulations and oncology pipeline unlock licensing, partnership and commercialization opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- "Canada RNA ...

Australia's drive to inoculate little penguins on Phillip Island against the H5N1 bird flu virus has spurred false claims the jab is an mRNA vaccine that will genetically modify the flightless ...